UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer, ISSN 0008-543X, 03/2010, Volume 116, Issue 6, pp. 1518 - 1525
Nonsmall cell lung cancer | Multimodality therapy | Long-term survival | Advanced stage | Staging | Lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Carcinoma, Non-Small-Cell Lung - pathology | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Neoplasm Metastasis | Time Factors | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Neoplasms, Multiple Primary - diagnosis | Pleural Effusion, Malignant - diagnosis | Care and treatment | Research | Lung cancer, Non-small cell | Patient outcomes | Combined modality therapy | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9974, pp. 1206 - 1218
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Age Distribution | Wales - epidemiology | Humans | Neoplasms - mortality | Male | Mortality - trends | Incidence | Young Adult | England - epidemiology | Adolescent | Survival Analysis | Aged, 80 and over | Sex Distribution | Adult | Female | Registries | Aged | Oncology, Experimental | Research | Cancer | Mens health | Womens health | Mortality | Medical prognosis | Trends | Patients | Age | Index Medicus | Abridged Index Medicus
Journal Article
Annals of surgical oncology, ISSN 1068-9265, 10/2015, Volume 22, Issue 10, pp. 3241 - 3249
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Breast Neoplasms - surgery | Prognosis | Mastectomy, Modified Radical - adverse effects | Humans | Mastectomy, Modified Radical - mortality | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - etiology | Disease-Free Survival | Breast Neoplasms - mortality | Female | Nipples - surgery | Mammaplasty | Organ Sparing Treatments - mortality | Medical colleges | Relapse | Analysis | Patient outcomes | Diseases | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 6, pp. 629 - 638
coronary artery disease | coronary revascularization | diabetes | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Diabetic Angiopathies - surgery | Coronary Artery Disease - surgery | Drug-Eluting Stents | Coronary Artery Disease - etiology | Follow-Up Studies | Humans | Middle Aged | Diabetic Angiopathies - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Survival Rate | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Artery Bypass | Diabetic Angiopathies - complications | Female | Aged | Percutaneous Coronary Intervention | Heart attacks | Angioplasty | Medical records | Cardiovascular disease | Drug delivery | Subgroups | Confidence intervals | Implants | Paclitaxel | Social insurance numbers | Hemoglobin | Heart diseases | Stents | Mortality | Medical treatment | Diabetes mellitus | Coronary artery | Hazards | Rapamycin | Coronary artery disease | Disease control | Patients | Survival | Investigations | Cholesterol | Statistical models | Coronary vessels | Health hazards | Fatalities | Diabetes
Journal Article
Cancer, ISSN 0008-543X, 04/2009, Volume 115, Issue 7, pp. 1531 - 1543
Bone cancer | Surveillance | Osteosarcoma | Epidemiology, and end results | Epidemiology | Survival | Incidence | Life Sciences & Biomedicine | Oncology | Science & Technology | Bone Neoplasms - mortality | Osteosarcoma - mortality | SEER Program | Age Factors | Humans | Middle Aged | Child, Preschool | Bone Neoplasms - epidemiology | Infant | Male | Survival Rate | Bone Neoplasms - pathology | Osteosarcoma - epidemiology | Ethnic Groups | Adolescent | Sex Factors | Aged, 80 and over | Adult | Female | Aged | Child | Infant, Newborn | Osteosarcoma - pathology | Patient outcomes | Distribution | Reports | Forecasts and trends | Research | Prevalence studies (Epidemiology) | Index Medicus | Abridged Index Medicus | bone cancer | epidemiology | SEER | incidence | osteosarcoma | survival
Journal Article
International journal of cancer, ISSN 0020-7136, 11/2019, Volume 145, Issue 10, pp. 2873 - 2883
outcome prediction | diagnosis | Epstein–Barr virus DNA | circulating tumor cells | metastatic nasopharyngeal carcinoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Herpesvirus 4, Human - genetics | Nasopharyngeal Neoplasms - mortality | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Nasopharyngeal Neoplasms - pathology | Young Adult | Herpesvirus 4, Human - isolation & purification | Nasopharyngeal Neoplasms - blood | Adult | Female | Nasopharyngeal Neoplasms - drug therapy | Nasopharyngeal Carcinoma - blood | Nasopharyngeal Carcinoma - mortality | Kaplan-Meier Estimate | Biomarkers, Tumor - blood | DNA, Viral - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Nasopharyngeal Carcinoma - pathology | Progression-Free Survival | Adolescent | Neoplastic Cells, Circulating | Nasopharyngeal Carcinoma - drug therapy | Aged | Biomarkers, Tumor - genetics | DNA, Viral - genetics | Chemotherapy | Carcinoma | Patient outcomes | DNA | Genetic research | Development and progression | Genetic aspects | Epstein-Barr virus | Metastasis | Cells | Cancer | Medical imaging | Cell survival | Tumor cells | Viruses | Survival | Metastases | Nasopharyngeal carcinoma | Medical prognosis | Diagnosis | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Human pathology, ISSN 0046-8177, 2017, Volume 64, pp. 7 - 12
Pathology | Breast carcinoma | Non-neoadjuvant therapy | Tumor-infiltrating lymphocytes | TIL | Disease-free survival | Overall survival | Adjuvant therapy | Life Sciences & Biomedicine | Science & Technology | Breast Neoplasms - surgery | Multivariate Analysis | Predictive Value of Tests | Breast Neoplasms - immunology | Humans | Receptors, Estrogen - analysis | Triple Negative Breast Neoplasms - immunology | Breast Neoplasms - chemistry | Triple Negative Breast Neoplasms - chemistry | Neoplasm Grading | Time Factors | Triple Negative Breast Neoplasms - surgery | Mastectomy | Female | Chemotherapy, Adjuvant | Odds Ratio | Biomarkers, Tumor - analysis | Risk Factors | Neoplasm Recurrence, Local | Proportional Hazards Models | Logistic Models | Treatment Outcome | Lymphatic Metastasis | Triple Negative Breast Neoplasms - mortality | Disease Progression | Disease-Free Survival | Biopsy | Breast Neoplasms - mortality | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Lymphocytes | Patient outcomes | Analysis | Estrogen | Adjuvant treatment | Phenols | Breast cancer | Cancer | Chemotherapy | Working groups | Estrogens | Melanoma | Metastasis | Multivariate analysis | Cancer therapies | Tumors | Immune system | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2008, Volume 112, Issue 10, pp. 2289 - 2300
life expectancy | testicular cancer | colorectal cancer | ovarian cancer | survival | cure | cause‐specific | Life expectancy | Cure | Colorectal cancer | Cause-specific | Survival | Testicular cancer | Ovarian cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Colorectal Neoplasms - epidemiology | Colorectal Neoplasms - mortality | SEER Program | Testicular Neoplasms - mortality | Humans | Middle Aged | Male | Survival Rate | Testicular Neoplasms - epidemiology | Models, Statistical | Ovarian Neoplasms - mortality | Ovarian Neoplasms - epidemiology | Disease-Free Survival | Time Factors | Life Expectancy | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Care and treatment | Patient outcomes | Models | Research | Cancer | Index Medicus | Abridged Index Medicus
Journal Article